✦ LIBER ✦

A multicenter, randomized trial of daily, high dose interferon-alpha 2b for the treatment of chronic hepatitis C: Prospective stratification by viral burden and genotype

✍ Scribed by Fried, MW; Shiffman, ML; Sterling, RK; Weinstein, J; Crippin, J; Garcia, G; Wright, TL; Conjeevaram, H; Reddy, RK; Peter, J; Cotsonis, G; Nolte, FS

Book ID: 122552905
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 203 KB
Volume: 114
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(98)85040-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter, randomized trial of daily

A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis C: pretreatment stratification by viral burden and genotype

✍ Michael W Fried; Mitchell Shiffman; Richard K Sterling; Jeffrey Weinstein; Jeffr 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 247 KB

Treatment of Chronic Hepatitis due to He

Treatment of Chronic Hepatitis due to Hepatitis C Virus (CH-C) in India: A Randomized Controlled Trial Comparing Daily Interferon-alfa-2b and Ribavirin with Daily Interferon-alfa-2b and Glycyrrhizin—A Multicenter Study

✍ Subrat K Acharya; V Sreenivas; Siddharth Datta Gupta; Shakti Kumar; Yogesh K Cha 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 186 KB

A randomized, double-blind controlled tr

A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy

✍ Zobair M Younossi; Kevin D Mullen; Wisam Zakko; Sandra Hodnick; Edward Brand; Da 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Daily dose of interferon alpha-2b and ri

Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study

✍ GianPiero Benetti; Mauro Borzio; Giuliano Ramella; Giorgio Bellati; Silvia Fargi 📂 Article 📅 2006 🏛 Springer Milan 🌐 English ⚖ 98 KB

Randomized, controlled trial including a

Randomized, controlled trial including an initial 4-week daily "induction" period during one year of high-dose interferon alfa-2b treatment for chronic hepatitis C

✍ Gonzales, Hernando J.; Ho, Samuel B.; Gross, John B.; Therneau, Terry; Peine, Cr 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Prolonged treatment (2 years) with diffe

Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon α-2b for chronic hepatitis type C: Results of a multicenter randomized trial

✍ Giorgio Saracco; Elisabetta Borghesio; Pietro Mesina; Antonello Solinas; Claudia 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 852 KB